HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kenji Ikezawa Selected Research
Kenji Ikezawa Research Topics
Disease
10
Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 12/2010
9
Neoplasms (Cancer)
05/2022 - 12/2010
4
Adenocarcinoma
04/2022 - 07/2017
3
Biliary Tract Neoplasms (Biliary Tract Cancer)
06/2021 - 02/2014
2
Hemorrhage
04/2022 - 11/2009
2
Pulmonary Embolism
04/2022 - 01/2022
2
Neoplasms, Cystic, Mucinous, and Serous
04/2020 - 05/2011
2
Liver Cirrhosis (Hepatic Cirrhosis)
12/2010 - 08/2007
1
Persistent Infection
05/2022
1
Virus Diseases (Viral Diseases)
05/2022
1
Hepatitis B
05/2022
1
Infections
05/2022
1
Obstructive Jaundice (Cholestatic Jaundice)
04/2022
1
Anemia
04/2022
1
Venous Thromboembolism
01/2022
1
Venous Thrombosis (Deep-Vein Thrombosis)
01/2022
1
Microsatellite Instability
06/2021
1
Cholangiocarcinoma
06/2021
1
Cholangitis
05/2021
1
Pathologic Complete Response
05/2021
1
Disease Progression
10/2020
1
Hepatocellular Carcinoma (Hepatoma)
04/2020
1
Thrombosis (Thrombus)
04/2020
1
Thromboembolism
04/2020
1
Sclerosing Cholangitis
07/2019
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2019
1
Pancreatitis
01/2018
1
Synovial Sarcoma (Synovioma)
09/2016
1
Neoplasm Metastasis (Metastasis)
09/2016
1
Jaundice (Icterus)
12/2013
1
Hemobilia
12/2013
1
False Aneurysm (Pseudoaneurysm)
12/2013
1
Acute Abdomen
12/2013
1
Pneumoperitoneum
01/2012
1
Thrombocytopenia (Thrombopenia)
12/2010
1
Hemangioma (Angioma)
11/2009
1
Disseminated Intravascular Coagulation
11/2009
1
Kasabach-Merritt Syndrome
11/2009
1
Fibrosis (Cirrhosis)
08/2007
Drug/Important Bio-Agent (IBA)
5
Gemcitabine
FDA Link
11/2022 - 12/2013
4
130-nm albumin-bound paclitaxel
IBA
11/2022 - 06/2021
3
Polysaccharides (Glycans)
IBA
01/2022 - 01/2021
3
Proteins (Proteins, Gene)
FDA Link
10/2019 - 08/2007
2
Leucovorin (Folinic Acid)
FDA Link
11/2022 - 06/2021
2
Fluorouracil (Carac)
FDA Link
Generic
11/2022 - 06/2021
2
Irinotecan (Camptosar)
FDA Link
Generic
11/2022 - 06/2021
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
11/2022 - 06/2021
2
Biomarkers (Surrogate Marker)
IBA
05/2022 - 04/2020
2
Sialyl Lewis X Antigen
IBA
01/2022 - 01/2021
2
Tumor Biomarkers (Tumor Markers)
IBA
01/2022 - 01/2021
1
DNA (Deoxyribonucleic Acid)
IBA
05/2022
1
RNA (Ribonucleic Acid)
IBA
05/2022
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
05/2022
1
alpha-aminopyridine
IBA
01/2022
1
Pharmaceutical Preparations
IBA
01/2022
1
Pentoses
IBA
01/2022
1
Arabinose (L-Arabinose)
IBA
01/2022
1
pembrolizumab
IBA
06/2021
1
Cyclin D1
IBA
05/2021
1
Enzymes
IBA
05/2021
1
N-acetylneuraminoyllactose
IBA
01/2021
1
N-acetyllactosamine
IBA
01/2021
1
Fucose
IBA
01/2021
1
Lactose
FDA Link
Generic
01/2021
1
Circulating Tumor DNA
IBA
10/2020
1
Tyrosine Kinase Inhibitors
IBA
04/2020
1
Sorafenib (BAY 43-9006)
FDA Link
04/2020
1
regorafenib
IBA
04/2020
1
lenvatinib
IBA
04/2020
1
Bilirubin
IBA
01/2020
1
Plastics
IBA
01/2020
1
mica
IBA
10/2019
1
Paclitaxel (Taxol)
FDA Link
Generic
07/2019
1
Bevacizumab (Avastin)
FDA Link
07/2019
1
Lipase (Acid Lipase)
FDA Link
01/2018
1
Messenger RNA (mRNA)
IBA
09/2016
1
Cyanoacrylates
IBA
12/2013
1
Protons (Proton)
IBA
12/2013
1
Indicators and Reagents (Reagents)
IBA
05/2011
1
danaparoid (Orgaran)
FDA Link
11/2009
1
Dacarbazine (DIC)
FDA Link
Generic
11/2009
1
Branched-Chain Amino Acids
IBA
08/2007
1
Zinc
IBA
08/2007
Therapy/Procedure
11
Drug Therapy (Chemotherapy)
11/2022 - 12/2010
6
Therapeutics
04/2022 - 08/2007
2
Stents
01/2020 - 12/2013
1
Folfox protocol
11/2022
1
Immunotherapy
05/2022
1
Self Expandable Metallic Stents
04/2022
1
Erythrocyte Transfusion
04/2022
1
Conservative Treatment
04/2022
1
Duodenoscopes
04/2022
1
Surgical Instruments (Clip)
03/2022
1
Chemoradiotherapy
09/2021
1
Induction Chemotherapy
09/2021
1
Neoadjuvant Therapy
01/2020
1
Adjuvant Chemotherapy
09/2016
1
Metastasectomy
09/2016
1
Radiotherapy
12/2013
1
Decompression
01/2012